Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Michael Glennon
AddedMar 31, 2024
UpdatedMay 31, 2026
Michael Glennon

Michael Glennon

Board Member, Pavmed

CrunchbaseLinkedIn

Michael Glennon's Career

Pavmed
Pavmed

New York City, NY, US

Board Member· Board
Cruzar Medsystems
Cruzar Medsystems

Braintree, MA, US

Board Member· Board
Saphena Medical
Saphena Medical

West Bridgewater, MA, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Michael Glennon's Career

Pavmed
Pavmed
Public$69M1242014New York City, NY, US
Board Member· Board

Leadership at Pavmed

Debbie WhiteDebbie WhiteBoard Member
Tim BaxterTim BaxterBoard Member
Lishan AklogLishan AklogBoard Member
Brian DeguzmanBrian DeguzmanCo-Founder
Daniel EngelmanDaniel EngelmanBoard Member

Similar to Pavmed

Lucid DiagnosticsLucid DiagnosticsNew York City, NY, USMedical Devicesest. 2018Lucid DiagnosticsNew York City, NY, US · est. 2018

Lucid Diagnostics, a PAVmed subsidiary, pioneers in cancer-prevention diagnostics with breakthrough devices.

Public · $18.6M129
Pavad MedicalPavad MedicalFremont, CA, USMedical Devicesest. 2002Pavad MedicalFremont, CA, US · est. 2002

Pavad Medical Inc., a US-based startup, provides innovative healthcare services via medical devices.

Series C · $23.6M30
Precision Medical ProductsPrecision Medical ProductsRocklin, CA, USMedical Equipmentest. 2010Precision Medical ProductsRocklin, CA, US · est. 2010

Precision Medical Products: A leading provider of state-of-the-art medical equipment, prioritizing patient care.

Pre-Seed · $500k154
PromedixPromedixPortland, OR, USMedical Devicesest. 2019PromedixPortland, OR, US · est. 2019

Promedix: Innovating home patient monitoring with medical devices for trauma, dehydration, and sepsis care.

Angel · $350k5
Cruzar Medsystems
Cruzar Medsystems
Series B$8.8M302013Braintree, MA, US
Board Member· Board

Leadership at Cruzar Medsystems

Thomas KramerThomas KramerCo-Founder
Albert ChinAlbert ChinCo-Founder
David TornatoreDavid TornatoreCEO

Similar to Cruzar Medsystems

Cross VascularCross VascularSolana Beach, CA, USMedical Devicesest. 2020Cross VascularSolana Beach, CA, US · est. 2020

Cross Vascular: A Solana Beach-based medical device company innovating in cardiovascular technologies since 2020.

Series A · $3.5M1
Traverse VascularTraverse VascularSolana Beach, CA, USMedical Devicesest. 2019Traverse VascularSolana Beach, CA, US · est. 2019

Traverse Vascular: Innovating chronic total occlusions treatment with breakthrough medical devices since 2019.

Pre-Seed · $1.1M1
Bluegrass Vascular TechnologiesBluegrass Vascular TechnologiesSan Antonio, TX, USMedical Devicesest. 2011Bluegrass Vascular TechnologiesSan Antonio, TX, US · est. 2011

Bluegrass Vascular Technologies: Innovating lifesaving vascular access devices and methods.

Series A · $4.5M6
Access VascularAccess VascularBedford, MA, USMedical Devicesest. 2015Access VascularBedford, MA, US · est. 2015

Access Vascular: Innovating venous access with novel hydrophilic-based medical devices.

Series C · $57.1M47
Saphena Medical
Saphena Medical
Series A$12.1M122013West Bridgewater, MA, US
Founder

Leadership at Saphena Medical

Mike GlennonMike GlennonBoard Member

Similar to Saphena Medical

Vena MedicalVena MedicalKitchener, Ontario, CAMedical Devices, Microcathetersest. 2016Vena MedicalKitchener, Ontario, CA · est. 2016

Vena Medical offers a microcatheter with the world's smallest camera for in-vessel physician viewing.

Angel · $220k10
Medical 21Medical 21Minneapolis, MN, USMedical Devicesest. 2016Medical 21Minneapolis, MN, US · est. 2016

Medical 21 develops innovative graft technology for heart bypass surgery, eliminating vessel harvesting.

Seed · $9.7M11
Venova MedicalVenova MedicalLos Gatos, CA, USMedical Devicesest. 2018Venova MedicalLos Gatos, CA, US · est. 2018

Venova Medical: Innovating vascular access systems for renal therapy, enhancing patient care since 2018.

Series A · $8M7
VenXVenXNashville, TN, USMedical Devicesest. 2009VenXNashville, TN, US · est. 2009

VenX Medical LLC, based in Nashville, develops minimally invasive devices for treating spider and reticular veins.

Angel · $2.5M7

Michael Glennon's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Michael Glennon

Mr. Paul Stashick J.Mr. Paul Stashick J.Board Member · SapheneiaGabino Roche JrGabino Roche JrCo-Founder · SaphyreHarvey HomanHarvey HomanCo-Founder · MetasTxJeff McLarenJeff McLarenBoard Member · HealthStreamJason PesterfieldJason PesterfieldBoard Member · Lumeda